• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    23.20
  • 漲跌
    ▼0.70
  • 漲幅
    -2.93%
  • 成交量
    482張
  • 產業
    上櫃 生技醫療類股▲0.08%

  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
健亞 (4130)籌碼相關－元大-成功 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

元大-成功 券商分點個股進出

元大-成功 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.00123.8023.90-1294-0.34%
2025/01/204.524.4200.0023.704.52831.57%
2025/01/171.125.0600.0025.201.12540.43%
2025/01/1600.002.425.2725.30-2.4225-1.07%
2025/01/15224.5023.224.4124.85-21.2187-11.31%
2025/01/1400.008.322.9322.95-8.3104-7.94%
2025/01/13121.1000.0020.901871.14%
2024/12/20020.950.120.8020.75-0.196-0.10%
2024/12/0300.00022.3521.95097-0.03%
2024/11/2700.00321.7521.75-3100-2.98%
2024/11/260.121.8000.0021.850.11000.10%
2024/11/250.121.8000.0021.800.11000.10%
2024/11/210.121.9500.0021.950.11020.10%
2024/11/200.121.9000.0021.950.11020.10%
2024/11/1900.00221.7821.95-2104-1.92%
2024/11/14122.0500.0021.9011080.92%
2024/11/13222.3500.0022.2021071.86%
2024/11/07222.3800.0022.3521111.80%
2024/10/280.222.5500.0022.550.21420.14%
2024/10/250.122.7500.0022.400.11440.07%
2024/10/24022.7500.0022.7001460.02%
2024/10/23022.7500.0022.8001480.00%
2024/10/170.122.3000.0022.300.11580.04%
2024/10/1600.00022.4022.1501600.00%
2024/10/0800.000.223.0522.75-0.2169-0.11%
2024/10/04223.1500.0023.2021781.12%
2024/09/30223.3500.0023.2521791.11%
2024/09/250.122.7000.0022.750.11810.06%
2024/09/240.122.6500.0022.600.11830.05%
2024/09/20023.0000.0022.3501910.00%
2024/09/1800.00122.0022.05-1195-0.51%
2024/09/16222.0000.0021.9521971.01%
2024/09/1300.00121.9021.85-1198-0.50%
2024/09/120.121.6000.0021.800.12010.05%
2024/09/09321.7000.0021.5032051.46%
2024/09/050.122.1000.0022.000.12050.05%
2024/09/020.122.6000.0022.100.12080.03%
2024/08/30022.6000.0022.6502090.01%
2024/08/280.122.5500.0022.550.12100.04%
2024/08/27022.3000.0022.3002130.01%
2024/08/0800.00122.4522.60-1226-0.44%
2024/08/05621.72221.6521.6542211.81%
2024/07/30122.8500.0023.1012170.46%
2024/07/26323.451023.2523.25-7214-3.27%
2024/07/22223.5800.0023.4022140.93%
2024/07/19824.1600.0023.9082113.78%
2024/07/15224.2500.0024.2022060.97%
2024/07/11124.0500.0024.0512050.49%
2024/07/09224.1500.0024.0522080.96%
2024/07/05124.7000.0024.7512060.48%
2024/07/03224.7500.0024.7522060.97%
2024/07/02124.7000.0024.7512070.48%
2024/07/0100.00224.6524.80-2205-0.98%
2024/06/2600.00224.6524.65-2195-1.02%
2024/06/2400.00724.7124.55-7192-3.65%
2024/06/21224.3500.0024.4521911.05%
2024/06/19624.4100.0024.3561903.15%
2024/06/1800.00324.7024.60-3189-1.58%
2024/06/17324.7500.0024.8031901.57%
2024/06/14224.5500.0024.6521881.06%
2024/06/13324.3500.0024.3531881.59%
2024/05/27323.9000.0023.9532041.47%
2024/05/2000.00324.4024.40-3220-1.36%
2024/05/1300.00223.7023.70-2229-0.87%
2024/05/10123.7000.0023.8512290.44%
2024/05/09123.9000.0023.8512270.44%
2024/05/03724.1200.0024.0572203.18%
2024/04/30124.2500.0024.4512150.46%
2024/04/24424.2800.0024.3042151.86%
2024/04/22123.950.124.1023.900.92170.42%
2024/03/25225.0000.0025.0022250.89%
2024/03/20024.9500.0024.7502300.00%
2024/03/14125.2500.0025.2012340.43%
2024/03/08125.5000.0025.0512410.41%
2024/02/2300.00225.6025.60-2273-0.73%
2024/02/20125.6000.0025.6012580.39%
2024/02/19225.5000.0025.5022590.77%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨－2022/09/12
...詳全文
健亞轉投資浩宇超音波D針具追蹤系統 獲美台上市許可UDN聯合新聞網－2022/05/09
健亞（4130）今（9）日宣布，轉投資浩宇生醫公司開發的NAVIRFA（納維爾）超音波3D手術針具追蹤系統，雙雙取得美、......詳全文
健亞轉拓資浩宇NaviFUS®產品 首獲研究用途設備訂單UDN聯合新聞網－2021/03/15
健亞（4130）今（15）日宣布，轉投資的浩宇生醫，下半年將取得肝癌治療產品NAVIRFA®之美國510（k）及台灣二類......詳全文
健亞 相關文章